The firm sees expenditure rising from $24bn to $34bn, a year-on-year growth of 11.5%. Global IT and networking spend is expected to increase from $975bn to $1.1trillion.
Datamonitor analyst Christopher Herrick believes the emergence of data-intensive areas such as genomics and proteomics will fuel investment in pharmaceutical sector.
“As vendors search for growth many are starting to tailor their product lines to match vertical needs. The pharmaceutical sector appears like a diamond in the rough as investment continues to flow into it from the beleaguered technology, media, and TMT sector,” said Herrick.
Just one half of UK practices have implemented a pricing structure around auto enrolment implementation and advice - with many suffering increased costs
Deloitte's north-west Europe foray; BDO, Smith & Williamson investment paths; Shelley Stock Hutter; and Wilkins Kennedy discussed by editor Kevin Reed on our Friday Afternoon Live broadcast
Accountants should alter their perspective on auto-enrolment to maximise business opportunities, according to Eric Clapton.
Kevin Reed discusses whether new accountancy group Cogital can rival the Big Four...and its likely direction of travel